Design, synthesis and biological evaluation of potential antitumor agents analogues from sanguinarine

Vol. 1, 2019 - 114192
Poster only
Favorite this paper
How to cite this paper?
Abstract

Sanguinarine is an alkaloid able to inhibit Bcl-xL, a protein which arrests cell death by apoptosis and is commonly overexpressed in tumor cells. Regarding to identify potential anticancer agents, two series of analogues from sanguinarine designed by molecular simplification were synthesized, and evaluated about their cytotoxic activity against U87 glioblastoma cells. Ten N-naphthyl-benzyl-amines and ten aryl-isoquinolines were synthesized and characterized by NMR 1H and 13C, HPLC and melting point. The most promising compound, the N-naphthyl-benzyl-amine derivative 4a, was, approximately, ten times more potent than the gold standard, temozolomide. This analogue induced cell cycle arrest at the G2/M phase, suggesting that it is a specific cell cycle compound. 4a further will be evaluated about its cell death mechanism and molecular docking will be performed in order to propose molecular interactions between the analogues and Bcl-xL. Our findings suggest that sanguinarine analogues may be a promising scaffold for designing antitumor agents.

Institutions
  • 1 Dante Pazzanese Institute of Cardiology
Track
  • 2. Medicinal Chemistry of Synthetic Compounds
Keywords
drug design
sanguinarine
molecular simplification
Bcl-xL
Câncer